Dan Schell articles

1. Why ING Feels Different 9/11/2026

   I’ve attended enough clinical trial conferences to know how similar they can feel. ING is different. Its Dive Teams, WhaleTank, and candid conversations are designed to get attendees participating, not just listening. This year, I’m especially interested in an off-the-record regulatory panel that could tackle some of the biggest changes facing clinical research.

2. What SIP Gets Right And Where It Still Falls Short 9/4/2026

   SIP users Sophie Haynes and Vicki Alvarez identify features that provide value but question whether the platform eliminates enough work to justify its setup demands, repetitive processes, and usability challenges.

3. The SIP Problem Is Bigger Than SIP 9/1/2026

   Sites continue to struggle with duplicated administrative work across too many sponsor and CRO systems. Current SIP users cite real frustrations with the platform, but their experiences also suggest the original goal of a shared, standardized site-information system remains highly relevant.

4. Building SIP Was The Hard Part 8/26/2026

   Charlie Semenchuk and Jeff Ventimiglia helped turn the ambitious vision for the Shared Investigator Platform into reality. They look back at SIP’s technical challenges, competing stakeholder needs, site burden, and what the experience can still teach an industry wrestling with many of the same problems today.

5. The Big Idea Behind The Creation Of SIP 8/20/2026

   Jackie Kent, Lisa Moneymaker, and Jeanette Teague were among the early architects of the Shared Investigator Platform (SIP). In part one of this four-part series, they discuss SIP’s ambitious origins, the challenges of getting competing sponsors to collaborate, and why broad adoption was critical to delivering on its promise of reducing site burden.

6. Rebecca Jackson: EHR-To-EDC Needs A Reality Check 8/10/2026

   Rebecca Jackson offers a candid reality check on EHR-to-EDC integration, AI, and clinical trial technology, arguing that innovation must solve real operational problems — not create new ones.

7. The Rare Trials Summit Wants To Produce More Than Conversation 8/3/2026

   The Rare Trials Summit returns to Boston this September with a mission that extends beyond traditional conference presentations. Through interactive workshops and working groups focused on regulatory guidance and pediatric trials, organizers hope to produce practical solutions that help advance rare disease clinical research.

8. When One Trial Leads To Rethinking Them All 7/22/2026

   A chance observation during the COVID-19 pandemic led physician-scientist Dan Nicolau to question one of clinical research's oldest assumptions. I spoke with Nicolau about the trial that changed his perspective and why he believes continuous trial analytics could reshape the future of clinical development.

9. From The Lab To Regulations As An IRB Specialist 7/17/2026

   In this 8-question Q&A, Ribu Goyal, an IRB specialist and scientific reviewer at the Mayo Clinic Office for Human Research Protection, talks about everything from the details of her job to how sponsors could improve their collaboration with their IRBs. 

10. A Role-Play Conference Session That Reframes The Data Manager's Job 7/14/2026

    A theatrical skit at the Clinical Trials Technology Congress (CTTC) in London imagined clinical data managers working alongside specialized AI agents by 2030. But the real takeaway wasn't about the technology. It was about how much of today's data manager role is work that shouldn't exist in the first place.